Nocturnal Hypertension

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-03-27
Clinical Trial Update: SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study) [Phase 4]
A Phase 4 SACRA clinical trial evaluating the combination of an SGLT-2 inhibitor with an ARB in patients with type 2 diabetes mellitus and n…